1Nagaya N,Nishikimi T,Uematsu M,et al.Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect.Am Heart J,1998,136:297-301.
2Cataliotti A,Malatino LS,Jougasaki M,et al.Circulating natriuretic peptide concentrations in patients with end-stage renal disease:role of brain natriuretic peptide as a biomarker for ventricular remodeling.Mayo Clin Proc,2001,76:1111-1119.
3Lisy O,Lainchbury JG,Leskinen H.Therapeutic action of a new synthetic vasoactive and natriuretic peptide,Dendroaspis natriuretic peptide in experimental sever congestive heart failure.Hypertension,2001,37:1089-1094.
4Kalra PR,Clague JR,Bolger AP,et al.Myocardial production of c-type natriuretic peptide in chronic heart failure.Circulation,2003,107(4):571-573.
5Ellmers LJ,Knowles JW,Kim HS,et al.Ventricular expression of natriuretic peptides in Npr1-mice with cardiac hypertrophy and fibrosis.AJP-Heart and circulatory phsiology,2002,283(2):707-714.
6James A,de Lemos,MD,et al.The prognostic values of B-type natriuretic peptide in patients with acute coronary syndromes.N Engl J Med,2001,345:1014-1021.
7Nagaya N,Nishikimi T,Uematsu M,et al.Plasma brain nariuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension.Circulation,2000,102:865-870.
8Nagaya N,Nishikimi T,Okano Y,et al.Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.J Am Coll Cardiol,1998,31:202-208.
